BioVie shareholders approve equity plan increase to 1.25M shares; all directors elected

BIOVIE INC.

All six director nominees (Lang, Do, Sherman, Berman, Hariri, Rogich) elected with majorities.
Ratification of EisnerAmper LLP as independent auditor for fiscal 2025 approved (4,526,100 for).
Non-binding say-on-pay proposal on executive compensation approved (3,004,131 for).
Amendment to 2019 Omnibus Equity Incentive Plan increasing authorized shares to 1,250,000 approved (2,963,641 for).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.